Akoustis Technologies (AKTS) PT Raised to $35 at H.C. Wainwright Jun 3, 2026 06:50AM
Aktis reports imaging data for cancer drug targeting B7-H3 protein May 21, 2026 05:36PM
William Blair Starts Akoustis Technologies (AKTS) at Outperform Apr 29, 2026 06:40AM
Akoustis Technologies (AKTS) PT Raised to $33 at H.C. Wainwright Mar 31, 2026 06:40AM
Aktis Oncology receives FDA clearance for AKY-2519 drug trials Mar 30, 2026 04:01PM


Mar 9, 2026 06:48AM H.C. Wainwright Starts Akoustis Technologies (AKTS) at Buy
Feb 3, 2026 06:15AM BofA Securities Starts Akoustis Technologies (AKTS) at Buy
Feb 3, 2026 06:13AM Leerink Partners Starts Akoustis Technologies (AKTS) at Outperform
Feb 3, 2026 05:29AM TD Cowen Starts Akoustis Technologies (AKTS) at Buy
Feb 3, 2026 02:29AM JPMorgan Starts Akoustis Technologies (AKTS) at Overweight
Jan 5, 2026 07:50AM Aktis Oncology seeks to raise $212 million in Nasdaq IPO
Jan 5, 2026 06:34AM Aktis Oncology (AKTS) files for 11.775M share IPO at $16-$18/sh
Dec 19, 2025 04:04PM Aktis Oncology (AKTS) files for proposed IPO
Aug 13, 2024 08:00AM Akoustis Technologies (AKTS) Receives an Additional $13M Purchase Order for XBAW Filters from Existing Tier-1 Customer
Jul 9, 2024 07:00AM Akoustis Technologies (AKTS) Secures $8M in Volume XBAW Orders with Tier-1 Customer
Jun 27, 2024 07:02AM Akoustis Technologies (AKTS) Reports $2M in Volume Orders for Wi-Fi 7 Program